Faecal microbiota transplants may influence COVID-19 severity, suggest researchers

By Will Chu

- Last updated on GMT

Faecal microbiota transplants may influence COVID-19 severity

Related tags COVID-19 FMT coronavirus

Tweaking the gut microbiome via a faecal microbiome transplant (FMT) may be worth further study as an approach to regulate the immune system in COVID-19 patients, researchers speculate.

In an article published in the Gut​ journal, two cases discussed feature patients treated with FMT primarily for Clostridioides difficile ​infection (CDI) but were given before symptoms of coexisting COVID-19 showed.

Both patients saw their virus symptoms disappear within days of receiving the transplant, prompting the team to point to the procedure as a possible way of stopping the infection in its tracks.  

“Our main conclusion from these cases is that FMT appears safe and of comparable efficacy in treating recurrent CDI in patients with coexisting COVID-19,” ​the team wrote.

A further, more speculative question is as to whether FMT may impact the clinical course of COVID-19.

Microbiome-immune interactions

“Both patients experienced mild clinical courses, with one possible explanation being that FMT mitigated more adverse outcomes, potentially through impacting microbiome-immune interactions.”

The team, from the Medical University of Warsaw in Poland, point out the patients, two males aged 80 and 19, were the only two cases the medics looked at and thus could not conclude the transplant ‘cured’ the COVID infection.

In addition, the elder patient also received the antiviral medication remdesivir and convalescent plasma (CP), a method of artificially inducing passive immunity.

However, clinical benefits from remdesivir usually occur after a median of 10 days, and clinical trials show limited benefits of CP in COVID-19.

The younger patient received no targeted therapy against COVID-19. Mean SARS-CoV-2 RNA presence in faeces of infected patients is 27.9 days (maximum of 47 days) after first symptom onset, which appears far longer than in our patients.

Earlier research

“Our experience is consistent with two further reported cases​ in which FMT, primarily administered to treat CDI, appeared safe and associated with rapid resolution of coexisting COVID-19,” ​the team adds.

Previous studies​ have demonstrated that SARS-CoV-2 may undergo prolonged shedding in stool, and that gut microbiome disturbances are associated with​ COVID-19 severity.

FMT restores a damaged gut microbiome and may impact on immune responses, including in the respiratory system (‘gut–lung axis’); such microbiome-immune signalling may result in lung-epithelial resistance​ to SARS-CoV-2.

Source: Gut

Published online: doi.org/10.1136/gutjnl-2021-325010

“Rapid resolution of COVID-19 after faecal microbiota transplantation.”

Authors: Biliński et al.

Related news

Show more

Related products

show more

Whitepaper: Discover a new era in postbiotics

Whitepaper: Discover a new era in postbiotics

Content provided by DSM Nutritional Products | 28-Nov-2023 | White Paper

Postbiotic ingredients are set to open up a world of opportunities across the human health and nutrition industry, fueled by developing science demonstrating...

Custom Biotic Solutions for Digestive Health

Custom Biotic Solutions for Digestive Health

Content provided by ADM: Innovation that Feeds the Future | 10-Oct-2023 | White Paper

A growing body of evidence shows gut health can affect digestive health, well-being, and many health areas in between.

Related suppliers

Follow us


View more